Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference
Amodio D. et al, (2025), Vaccine, 43
GeM-LR: Discovering predictive biomarkers for small datasets in vaccine studies.
Lin L. et al, (2024), PLoS Comput Biol, 20
Respiratory Syncytial Virus-related Community Chronic Obstructive Pulmonary Disease Exacerbations and Novel Diagnostics: A Binational Prospective Cohort Study.
Wiseman DJ. et al, (2024), Am J Respir Crit Care Med, 210, 994 - 1001
5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.
Qadri F. et al, (2024), Lancet, 404, 1419 - 1429
New programme to prevent bronchiolitis in infants
Pollard AJ. et al, (2024), Archives of Disease in Childhood
A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens.
Pinto MV. et al, (2024), J Immunol Methods, 534
What have we learned from animal studies of immune responses to respiratory syncytial virus infection?
Drysdale SB. et al, (2024), J Clin Virol, 175
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial.
Williams LR. et al, (2024), Vaccine, 42
Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.
Costa Clemens SA. et al, (2024), Lancet Microbe, 5
Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: A pre-post comparison study.
Kandasamy R. et al, (2024), Vaccine, 42, 4066 - 4071
Characterising the molecular epidemiology of human parechovirus in young infants in the UK and Canada.
Kadambari S. et al, (2024), J Clin Virol, 174
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.
Feng S. et al, (2024), Health Technol Assess, 28, 1 - 109
Inflammation of the nasal mucosa is associated with susceptibility to experimental pneumococcal challenge in older adults.
Urban BC. et al, (2024), Mucosal Immunol
Towards paratyphoid control: the vital role of the challenge model
McCann N. et al, (2024), The Lancet, 403, 2780 - 2781